Independent AI index
for professionals

Home / Safety / Owkin K Pro for the pharmaceutical industry

Owkin (Paris, France)

How safe is Owkin K Pro for the pharmaceutical industry?

GDPR profileOur summary of what the provider itself publishes about your data: whether the data is stored in the EU (2 points), whether there is certification or a GDPR guarantee (1) and whether the provider is established in the NL or the EU (1). 3 or 4 points is Strong, 2 Good, 1 Limited, 0 Unknown. How we measure for the pharmaceutical industryLimited

Owkin K Pro publishes limited privacy safeguards. Ask the provider for clarification before you put confidential pharmaceutical industry data into it.

Where does Owkin K Pro stand in the pharmaceutical industry?

Shared spot 9 of 25 options for the pharmaceutical industry (professional tools and general assistants) on the GDPR profile. 7 options, like Owkin K Pro, have a limited profile. Each tile is an option we track for this field; click to check.

Strong5
Good3
Limited7
Unknown3
Caution7

Published safeguards

✓Provider based in NL/EUYes
–Data in the EU (according to provider)Not known
–Publishes certification (ISO/NEN/GDPR)Not known

not publicly disclosed which language models K Pro uses (multi-agent architecture). Works with multimodal patient data from a network of 840 hospitals; hosting and training on customer data not stated on the homepage.

How to use Owkin K Pro safely

  • Use the business variant and sign a data processing agreement (DPA).
  • Do not enter unnecessary personal data into prompts; anonymise where possible.
  • Enable EU data residency where the provider offers it.
  • Keep a professional in the loop: in this sector it concerns health data of trial participants and patients (special category personal data under art.

Stronger or equally strong in the pharmaceutical industry

CradleCradle (Amsterdam, the Netherlands and Zürich, Switzerland)CastorCastor (Amsterdam, Netherlands)BiolevateBiolevate (Paris, France)Aily LabsAily Labs GmbH (Munich, Germany)ClaudeAnthropic

Questions

How safe is Owkin K Pro for the pharmaceutical industry?
Owkin K Pro publishes limited privacy safeguards. Ask the provider for clarification before you put confidential pharmaceutical industry data into it. For limited or partly unknown safeguards, check with the provider.
Does Owkin K Pro train on my data?
not publicly disclosed which language models K Pro uses (multi-agent architecture). Works with multimodal patient data from a network of 840 hospitals; hosting and training on customer data not stated on the homepage.
What should I look out for with AI in the pharmaceutical industry?
This sector involves health data of trial participants and patients (special category personal data under Article 9 GDPR) and confidential research data. Ask every provider where the data is stored and whether it is used to train models: Castor hosts in the Netherlands (Google Cloud europe-west4) and does not share data or models between customers, Cradle states that source data never goes to third-party AI models, Iris.ai hosts on AWS in Ireland and Germany. Biolevate and Ennov also run in private cloud or on-premises. With Veeva Vault AI and Yseop, texts go to Anthropic models via Amazon Bedrock; check the region and the data processing agreement. If you work in GxP processes, an AI tool must also be validated (EU GMP Annex 11) and a competent employee remains responsible. For AI in medicines development, the EMA has a reflection paper (2024) and is working with the FDA on joint principles.

Source documents

www.owkin.com

Everything about Owkin K Pro Best AI for the pharmaceutical industry

Summarised by the editorial team from provider documentation · not legal advice

Last checked: 3 November 2026 · How we check

Next stepAll 25 options for pharmaceutical industryProfessional tools and general assistants side by side, on GDPR profile, price and quality.

Every Friday: what changed in AI for the pharmaceutical industry

New models, prices, oversight and tools, with sources and what it means for you. One email a week, unsubscribe with one click.

View a sample

We only use your address for this newsletter. You confirm first by email.